Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1472542

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1472542

Europe Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Cattle, and Sheep & Goats), By Vaccines Type, By Route of Administration, By Indication, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 135 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Ruminant Vaccines Market would witness market growth of 6.3% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Ruminant Vaccines Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $331.1 million by 2031. The UK market is exhibiting a CAGR of 5.3% during (2024 - 2031). Additionally, The France market would experience a CAGR of 7.1% during (2024 - 2031).

Vaccines targeting respiratory pathogens such as Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Bovine Respiratory Syncytial Virus (BRSV) are used to prevent diseases like bovine respiratory disease complex (BRDC), contagious caprine pleuropneumonia (CCPP), and ovine pulmonary adenocarcinoma (OPA). Vaccination helps reduce the incidence and severity of respiratory infections, decrease antibiotic usage, and improve animal welfare.

Similarly, reproductive disorders can have significant economic implications for ruminant producers due to reduced fertility, abortions, and neonatal mortality. Vaccines targeting reproductive pathogens such as Brucella abortus, Chlamydia spp., and bovine herpesvirus 1 (BHV-1) are used to prevent diseases like brucellosis, campylobacteriosis, and infectious bovine rhinotracheitis (IBR). Vaccination helps maintain herd fertility, reduce reproductive losses, and prevent the spread of sexually transmitted infections among breeding animals.

Europe is a major meat producer, including beef, veal, lamb, and mutton. As per Eurostat, at the end of 2022, there were 134 million pigs, 75 million bovine animals, and 70 million sheep and goats in the EU. The EU produced a provisional 6.6 million tons of bovine meat (beef and veal carcasses) by 2022. About 70 % of the EU's veal meat was produced in three countries, the Netherlands (26.9 %), Spain (22.9 %), and France (18.9 %). In conclusion, the region's high meat production promotes the market's growth.

Based on Animal Type, the market is segmented into Cattle, and Sheep & Goats. Based on Vaccines Type, the market is segmented into Modified/ Attenuated Live, Inactivated (Killed), and Others. Based on Route of Administration, the market is segmented into Injectable, and Intranasal. Based on Indication, the market is segmented into Bovine Respiratory Diseases (BRD), Diarrhea/ Scours, FMD, Clostridial Diseases, Leptospirosis, BVD Infection, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Boehringer Ingelheim International GmbH
  • Zoetis, Inc.
  • Merck & Co., Inc.
  • Bimeda, Inc.
  • Elanco Animal Health, Inc.
  • Virbac
  • Ceva Sante Animale
  • CZ Vaccines S.A.U. (Zendal Health S.A.)
  • Indian Immunologicals Ltd. (National Dairy Development Board)
  • Vaxxinova International BV (EW Group)

Europe Ruminant Vaccines Market Report Segmentation

By Animal Type

  • Cattle
  • Sheep & Goats

By Vaccines Type

  • Modified/ Attenuated Live
  • Inactivated (Killed)
  • Others

By Route of Administration

  • Injectable
  • Intranasal

By Indication

  • Bovine Respiratory Diseases (BRD)
  • Diarrhea/ Scours
  • FMD
  • Clostridial Diseases
  • Leptospirosis
  • BVD Infection
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1Europe Ruminant Vaccines Market, by Animal Type
    • 1.4.2Europe Ruminant Vaccines Market, by Vaccines Type
    • 1.4.3Europe Ruminant Vaccines Market, by Route of Administration
    • 1.4.4Europe Ruminant Vaccines Market, by Indication
    • 1.4.5Europe Ruminant Vaccines Market, by Country
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Opportunities
    • 3.2.3Market Restraints
    • 3.2.4Market Challenges
  • 3.3Porter's Five Forces Analysis

Chapter 4.Recent strategies deployed in Ruminant Vaccines Market

Chapter 5.Europe Ruminant Vaccines Market by Animal Type

  • 5.1Europe Cattle Market by Country
  • 5.2Europe Sheep & Goats Market by Country

Chapter 6.Europe Ruminant Vaccines Market by Vaccines Type

  • 6.1Europe Modified/ Attenuated Live Market by Country
  • 6.2Europe Inactivated (Killed) Market by Country
  • 6.3Europe Others Market by Country

Chapter 7.Europe Ruminant Vaccines Market by Route of Administration

  • 7.1Europe Injectable Market by Country
  • 7.2Europe Intranasal Market by Country

Chapter 8.Europe Ruminant Vaccines Market by Indication

  • 8.1Europe Bovine Respiratory Diseases (BRD) Market by Country
  • 8.2Europe Diarrhea/ Scours Market by Country
  • 8.3Europe FMD Market by Country
  • 8.4Europe Clostridial Diseases Market by Country
  • 8.5Europe Leptospirosis Market by Country
  • 8.6Europe BVD Infection Market by Country
  • 8.7Europe Others Market by Country

Chapter 9.Europe Ruminant Vaccines Market by Country

  • 9.1Germany Ruminant Vaccines Market
    • 9.1.1Germany Ruminant Vaccines Market by Animal Type
    • 9.1.2Germany Ruminant Vaccines Market by Vaccines Type
    • 9.1.3Germany Ruminant Vaccines Market by Route of Administration
    • 9.1.4Germany Ruminant Vaccines Market by Indication
  • 9.2UK Ruminant Vaccines Market
    • 9.2.1UK Ruminant Vaccines Market by Animal Type
    • 9.2.2UK Ruminant Vaccines Market by Vaccines Type
    • 9.2.3UK Ruminant Vaccines Market by Route of Administration
    • 9.2.4UK Ruminant Vaccines Market by Indication
  • 9.3France Ruminant Vaccines Market
    • 9.3.1France Ruminant Vaccines Market by Animal Type
    • 9.3.2France Ruminant Vaccines Market by Vaccines Type
    • 9.3.3France Ruminant Vaccines Market by Route of Administration
    • 9.3.4France Ruminant Vaccines Market by Indication
  • 9.4Russia Ruminant Vaccines Market
    • 9.4.1Russia Ruminant Vaccines Market by Animal Type
    • 9.4.2Russia Ruminant Vaccines Market by Vaccines Type
    • 9.4.3Russia Ruminant Vaccines Market by Route of Administration
    • 9.4.4Russia Ruminant Vaccines Market by Indication
  • 9.5Spain Ruminant Vaccines Market
    • 9.5.1Spain Ruminant Vaccines Market by Animal Type
    • 9.5.2Spain Ruminant Vaccines Market by Vaccines Type
    • 9.5.3Spain Ruminant Vaccines Market by Route of Administration
    • 9.5.4Spain Ruminant Vaccines Market by Indication
  • 9.6Italy Ruminant Vaccines Market
    • 9.6.1Italy Ruminant Vaccines Market by Animal Type
    • 9.6.2Italy Ruminant Vaccines Market by Vaccines Type
    • 9.6.3Italy Ruminant Vaccines Market by Route of Administration
    • 9.6.4Italy Ruminant Vaccines Market by Indication
  • 9.7Rest of Europe Ruminant Vaccines Market
    • 9.7.1Rest of Europe Ruminant Vaccines Market by Animal Type
    • 9.7.2Rest of Europe Ruminant Vaccines Market by Vaccines Type
    • 9.7.3Rest of Europe Ruminant Vaccines Market by Route of Administration
    • 9.7.4Rest of Europe Ruminant Vaccines Market by Indication

Chapter 10.Company Profiles

  • 10.1Boehringer Ingelheim International GmbH
    • 10.1.1Company Overview
    • 10.1.2Financial Analysis
    • 10.1.3Regional & Segmental Analysis
    • 10.1.4Research & Development Expenses
    • 10.1.5Recent strategies and developments:
      • 10.1.5.1Partnerships, Collaborations, and Agreements:
      • 10.1.5.2Product Launches and Product Expansions:
      • 10.1.5.3Geographical Expansions:
    • 10.1.6SWOT Analysis
  • 10.2Zoetis, Inc.
    • 10.2.1Company Overview
    • 10.2.2Financial Analysis
    • 10.2.3Regional Analysis
    • 10.2.4Research & Development Expenses
    • 10.2.5Recent strategies and developments:
      • 10.2.5.1Product Launches and Product Expansions:
    • 10.2.6SWOT Analysis
  • 10.3Merck & Co., Inc.
    • 10.3.1Company Overview
    • 10.3.2Financial Analysis
    • 10.3.3Segmental and Regional Analysis
    • 10.3.4Research & Development Expenses
    • 10.3.5Recent strategies and developments:
      • 10.3.5.1Product Launches and Product Expansions:
    • 10.3.6SWOT Analysis
  • 10.4Bimeda, Inc.
    • 10.4.1Company Overview
    • 10.4.2SWOT Analysis
  • 10.5Elanco Animal Health, Inc.
    • 10.5.1Company Overview
    • 10.5.2Financial Analysis
    • 10.5.3Regional Analysis
    • 10.5.4Research & Development Expenses
    • 10.5.5SWOT Analysis
  • 10.6Virbac
    • 10.6.1Company Overview
    • 10.6.2Financial Analysis
    • 10.6.3Regional Analysis
    • 10.6.4SWOT Analysis
  • 10.7Ceva Sante Animale
    • 10.7.1Company Overview
    • 10.7.2Recent strategies and developments:
      • 10.7.2.1Acquisition and Mergers:
    • 10.7.3SWOT Analysis
  • 10.8CZ Vaccines S.A.U. (Zendal Health S.A.)
    • 10.8.1Company Overview
    • 10.8.2SWOT Analysis
  • 10.9Indian Immunologicals Ltd. (National Dairy Development Board)
    • 10.9.1Company Overview
    • 10.9.2Financial Analysis
    • 10.9.3Research & Development Expenses
    • 10.9.4SWOT Analysis
  • 10.10.Vaxxinova International BV (EW Group)
    • 10.10.1Company Overview
    • 10.10.2SWOT Analysis

LIST OF TABLES

  • TABLE 1Europe Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 2Europe Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 3Europe Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 4Europe Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 5Europe Cattle Market by Country, 2020 - 2023, USD Million
  • TABLE 6Europe Cattle Market by Country, 2024 - 2031, USD Million
  • TABLE 7Europe Sheep & Goats Market by Country, 2020 - 2023, USD Million
  • TABLE 8Europe Sheep & Goats Market by Country, 2024 - 2031, USD Million
  • TABLE 9Europe Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 10Europe Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 11Europe Modified/ Attenuated Live Market by Country, 2020 - 2023, USD Million
  • TABLE 12Europe Modified/ Attenuated Live Market by Country, 2024 - 2031, USD Million
  • TABLE 13Europe Inactivated (Killed) Market by Country, 2020 - 2023, USD Million
  • TABLE 14Europe Inactivated (Killed) Market by Country, 2024 - 2031, USD Million
  • TABLE 15Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 16Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 17Europe Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 18Europe Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 19Europe Injectable Market by Country, 2020 - 2023, USD Million
  • TABLE 20Europe Injectable Market by Country, 2024 - 2031, USD Million
  • TABLE 21Europe Intranasal Market by Country, 2020 - 2023, USD Million
  • TABLE 22Europe Intranasal Market by Country, 2024 - 2031, USD Million
  • TABLE 23Europe Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 24Europe Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 25Europe Bovine Respiratory Diseases (BRD) Market by Country, 2020 - 2023, USD Million
  • TABLE 26Europe Bovine Respiratory Diseases (BRD) Market by Country, 2024 - 2031, USD Million
  • TABLE 27Europe Diarrhea/ Scours Market by Country, 2020 - 2023, USD Million
  • TABLE 28Europe Diarrhea/ Scours Market by Country, 2024 - 2031, USD Million
  • TABLE 29Europe FMD Market by Country, 2020 - 2023, USD Million
  • TABLE 30Europe FMD Market by Country, 2024 - 2031, USD Million
  • TABLE 31Europe Clostridial Diseases Market by Country, 2020 - 2023, USD Million
  • TABLE 32Europe Clostridial Diseases Market by Country, 2024 - 2031, USD Million
  • TABLE 33Europe Leptospirosis Market by Country, 2020 - 2023, USD Million
  • TABLE 34Europe Leptospirosis Market by Country, 2024 - 2031, USD Million
  • TABLE 35Europe BVD Infection Market by Country, 2020 - 2023, USD Million
  • TABLE 36Europe BVD Infection Market by Country, 2024 - 2031, USD Million
  • TABLE 37Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 38Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 39Europe Ruminant Vaccines Market by Country, 2020 - 2023, USD Million
  • TABLE 40Europe Ruminant Vaccines Market by Country, 2024 - 2031, USD Million
  • TABLE 41Germany Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 42Germany Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 43Germany Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 44Germany Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 45Germany Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 46Germany Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 47Germany Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 48Germany Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 49Germany Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 50Germany Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 51UK Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 52UK Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 53UK Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 54UK Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 55UK Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 56UK Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 57UK Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 58UK Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 59UK Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 60UK Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 61France Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 62France Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 63France Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 64France Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 65France Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 66France Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 67France Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 68France Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 69France Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 70France Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 71Russia Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 72Russia Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 73Russia Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 74Russia Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 75Russia Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 76Russia Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 77Russia Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 78Russia Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 79Russia Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 80Russia Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 81Spain Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 82Spain Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 83Spain Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 84Spain Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 85Spain Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 86Spain Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 87Spain Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 88Spain Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 89Spain Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 90Spain Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 91Italy Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 92Italy Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 93Italy Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 94Italy Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 95Italy Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 96Italy Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 97Italy Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 98Italy Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 99Italy Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 100Italy Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 101Rest of Europe Ruminant Vaccines Market, 2020 - 2023, USD Million
  • TABLE 102Rest of Europe Ruminant Vaccines Market, 2024 - 2031, USD Million
  • TABLE 103Rest of Europe Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
  • TABLE 104Rest of Europe Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
  • TABLE 105Rest of Europe Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
  • TABLE 106Rest of Europe Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
  • TABLE 107Rest of Europe Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 108Rest of Europe Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 109Rest of Europe Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
  • TABLE 110Rest of Europe Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
  • TABLE 111Key Information - Boehringer Ingelheim International GmbH
  • TABLE 112Key Information - Zoetis, Inc.
  • TABLE 113Key Information - Merck & Co., Inc.
  • TABLE 114Key Information - Bimeda, Inc.
  • TABLE 115Key information - Elanco Animal Health, Inc.
  • TABLE 116Key Information - Virbac
  • TABLE 117Key Information - Ceva SantE Animale
  • TABLE 118Key Information - CZ Vaccines S.A.U.
  • TABLE 119Key Information - Indian Immunologicals Ltd.
  • TABLE 120Key Information - Vaxxinova International BV
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!